APO Research
Talk to an analyst

APO RESEARCH · REPORT

Follicular Thyroid Cancer Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Follicular Thyroid Cancer Drug Industry Growth and Trends Forecast to 2032

26 December 202590 pages

Choose your research edition.

Industry ResearchFollicular Thyroid Cancer Drug Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Follicular Thyroid Cancer Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Follicular Thyroid Cancer Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Follicular Thyroid Cancer Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Follicular Thyroid Cancer Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Follicular Thyroid Cancer Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Follicular Thyroid Cancer Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Follicular Thyroid Cancer Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Follicular Thyroid Cancer Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Follicular Thyroid Cancer Drug include Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Exelixis, Inc. and AstraZeneca PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Follicular Thyroid Cancer Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Follicular Thyroid Cancer Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Follicular Thyroid Cancer Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Follicular Thyroid Cancer Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Follicular Thyroid Cancer Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Follicular Thyroid Cancer Drug Market by Company

Novartis AG

Pfizer Inc.

GlaxoSmithKline plc

Exelixis, Inc.

AstraZeneca PLC

Follicular Thyroid Cancer Drug Segment by Type

Dabrafenib Mesylate

Cabozantinib S-Malate

Sunitinib Malate

Everolimus

Others

Follicular Thyroid Cancer Drug Segment by Application

Hospital

Clinic

Others

Follicular Thyroid Cancer Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Follicular Thyroid Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Follicular Thyroid Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Follicular Thyroid Cancer Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Follicular Thyroid Cancer Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Follicular Thyroid Cancer Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dabrafenib Mesylate Table 2. Major Company of Cabozantinib S-Malate Table 3. Major Company of Sunitinib Malate Table 4. Major Company of Everolimus Table 5. Major Company of Others Table 6. Global Follicular Thyroid Cancer Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (W Units) Table 8. Global Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Follicular Thyroid Cancer Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Follicular Thyroid Cancer Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Follicular Thyroid Cancer Drug Sales by Type (2027-2032) & (W Units) Table 13. Global Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Follicular Thyroid Cancer Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Follicular Thyroid Cancer Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Follicular Thyroid Cancer Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (W Units) Table 18. North America Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (W Units) Table 20. Europe Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (W Units) Table 24. Latin America Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Follicular Thyroid Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Follicular Thyroid Cancer Drug Industry Trends Table 28. Follicular Thyroid Cancer Drug Industry Drivers Table 29. Follicular Thyroid Cancer Drug Industry Opportunities and Challenges Table 30. Follicular Thyroid Cancer Drug Industry Restraints Table 31. Global Follicular Thyroid Cancer Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Follicular Thyroid Cancer Drug Revenue Market Share by Company (2021-2026) Table 33. Global Follicular Thyroid Cancer Drug Sales by Company (2021-2026) & (W Units) Table 34. Global Follicular Thyroid Cancer Drug Sales Share by Company (2021-2026) Table 35. Global Follicular Thyroid Cancer Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Follicular Thyroid Cancer Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Follicular Thyroid Cancer Drug Major Company Production Sites and Headquarters Table 38. Global Follicular Thyroid Cancer Drug Company, Product Type & Application Table 39. Global Follicular Thyroid Cancer Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Follicular Thyroid Cancer Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Follicular Thyroid Cancer Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Follicular Thyroid Cancer Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Follicular Thyroid Cancer Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Follicular Thyroid Cancer Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Follicular Thyroid Cancer Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Follicular Thyroid Cancer Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Follicular Thyroid Cancer Drug Sales by Region (2027-2032) & (W Units) Table 49. Global Follicular Thyroid Cancer Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Follicular Thyroid Cancer Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Follicular Thyroid Cancer Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Follicular Thyroid Cancer Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Follicular Thyroid Cancer Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (W Units) Table 55. Global Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Follicular Thyroid Cancer Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Follicular Thyroid Cancer Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Follicular Thyroid Cancer Drug Sales by Application (2027-2032) & (W Units) Table 60. Global Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Follicular Thyroid Cancer Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Follicular Thyroid Cancer Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Follicular Thyroid Cancer Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (W Units) Table 65. North America Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (W Units) Table 67. Europe Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (W Units) Table 71. Latin America Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Follicular Thyroid Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Follicular Thyroid Cancer Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Follicular Thyroid Cancer Drug Product Portfolio Table 78. Novartis AG Recent Development Table 79. Pfizer Inc. Company Information Table 80. Pfizer Inc. Business Overview Table 81. Pfizer Inc. Follicular Thyroid Cancer Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pfizer Inc. Follicular Thyroid Cancer Drug Product Portfolio Table 83. Pfizer Inc. Recent Development Table 84. GlaxoSmithKline plc Company Information Table 85. GlaxoSmithKline plc Business Overview Table 86. GlaxoSmithKline plc Follicular Thyroid Cancer Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline plc Follicular Thyroid Cancer Drug Product Portfolio Table 88. GlaxoSmithKline plc Recent Development Table 89. Exelixis, Inc. Company Information Table 90. Exelixis, Inc. Business Overview Table 91. Exelixis, Inc. Follicular Thyroid Cancer Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Exelixis, Inc. Follicular Thyroid Cancer Drug Product Portfolio Table 93. Exelixis, Inc. Recent Development Table 94. AstraZeneca PLC Company Information Table 95. AstraZeneca PLC Business Overview Table 96. AstraZeneca PLC Follicular Thyroid Cancer Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. AstraZeneca PLC Follicular Thyroid Cancer Drug Product Portfolio Table 98. AstraZeneca PLC Recent Development Table 99. North America Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 100. North America Follicular Thyroid Cancer Drug Sales by Country (2021-2026) & (W Units) Table 101. North America Follicular Thyroid Cancer Drug Sales Market Share by Country (2021-2026) Table 102. North America Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032) & (W Units) Table 103. North America Follicular Thyroid Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 104. North America Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Follicular Thyroid Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Follicular Thyroid Cancer Drug Market Share by Country (2021-2026) Table 107. North America Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Follicular Thyroid Cancer Drug Market Share Forecast by Country (2027-2032) Table 109. Europe Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. Europe Follicular Thyroid Cancer Drug Sales by Country (2021-2026) & (W Units) Table 111. Europe Follicular Thyroid Cancer Drug Sales Market Share by Country (2021-2026) Table 112. Europe Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032) & (W Units) Table 113. Europe Follicular Thyroid Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Follicular Thyroid Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Follicular Thyroid Cancer Drug Market Share by Country (2021-2026) Table 117. Europe Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Follicular Thyroid Cancer Drug Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Follicular Thyroid Cancer Drug Sales by Country (2021-2026) & (W Units) Table 121. Asia-Pacific Follicular Thyroid Cancer Drug Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032) & (W Units) Table 123. Asia-Pacific Follicular Thyroid Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Follicular Thyroid Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Follicular Thyroid Cancer Drug Market Share by Country (2021-2026) Table 127. Asia-Pacific Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Follicular Thyroid Cancer Drug Market Share Forecast by Country (2027-2032) Table 129. Latin America Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Latin America Follicular Thyroid Cancer Drug Sales by Country (2021-2026) & (W Units) Table 131. Latin America Follicular Thyroid Cancer Drug Sales Market Share by Country (2021-2026) Table 132. Latin America Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032) & (W Units) Table 133. Latin America Follicular Thyroid Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Follicular Thyroid Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Follicular Thyroid Cancer Drug Market Share by Country (2021-2026) Table 137. Latin America Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Follicular Thyroid Cancer Drug Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Follicular Thyroid Cancer Drug Sales by Country (2021-2026) & (W Units) Table 141. Middle East and Africa Follicular Thyroid Cancer Drug Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032) & (W Units) Table 143. Middle East and Africa Follicular Thyroid Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Follicular Thyroid Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Follicular Thyroid Cancer Drug Market Share by Country (2021-2026) Table 147. Middle East and Africa Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Follicular Thyroid Cancer Drug Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Follicular Thyroid Cancer Drug Distributors List Table 152. Follicular Thyroid Cancer Drug Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Follicular Thyroid Cancer Drug Image Figure 2. Global Follicular Thyroid Cancer Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Follicular Thyroid Cancer Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Follicular Thyroid Cancer Drug Sales (2021-2032) & (W Units) Figure 5. Dabrafenib Mesylate Image Figure 6. Global Dabrafenib Mesylate Sales YoY Growth (2021-2032) & (W Units) Figure 7. Cabozantinib S-Malate Image Figure 8. Global Cabozantinib S-Malate Sales YoY Growth (2021-2032) & (W Units) Figure 9. Sunitinib Malate Image Figure 10. Global Sunitinib Malate Sales YoY Growth (2021-2032) & (W Units) Figure 11. Everolimus Image Figure 12. Global Everolimus Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Follicular Thyroid Cancer Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Follicular Thyroid Cancer Drug Market Share by Type 2025 VS 2032 Figure 17. North America Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Follicular Thyroid Cancer Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Follicular Thyroid Cancer Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Follicular Thyroid Cancer Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Follicular Thyroid Cancer Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Follicular Thyroid Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Follicular Thyroid Cancer Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Follicular Thyroid Cancer Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Follicular Thyroid Cancer Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Follicular Thyroid Cancer Drug Market Share by Application 2025 VS 2032 Figure 37. North America Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Follicular Thyroid Cancer Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Follicular Thyroid Cancer Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Follicular Thyroid Cancer Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Follicular Thyroid Cancer Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Follicular Thyroid Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Follicular Thyroid Cancer Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Follicular Thyroid Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Follicular Thyroid Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Follicular Thyroid Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Follicular Thyroid Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Follicular Thyroid Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Follicular Thyroid Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Follicular Thyroid Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Follicular Thyroid Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Follicular Thyroid Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Follicular Thyroid Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Follicular Thyroid Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Follicular Thyroid Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Follicular Thyroid Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Follicular Thyroid Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Follicular Thyroid Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Follicular Thyroid Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Follicular Thyroid Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Follicular Thyroid Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Follicular Thyroid Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Follicular Thyroid Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Follicular Thyroid Cancer Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Follicular Thyroid Cancer Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dabrafenib Mesylate
  • Cabozantinib S-Malate
  • Sunitinib Malate
  • Everolimus
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Exelixis, Inc.
  • AstraZeneca PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Follicular Thyroid Cancer Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Follicular Thyroid Cancer Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Follicular Thyroid Cancer Drug Market by Type
  6. 1.3.1 Dabrafenib Mesylate
  7. 1.3.2 Cabozantinib S-Malate
  8. 1.3.3 Sunitinib Malate
  9. 1.3.4 Everolimus
  10. 1.3.5 Others
  11. 1.4 Global Follicular Thyroid Cancer Drug Market Size by Type
  12. 1.4.1 Global Follicular Thyroid Cancer Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Follicular Thyroid Cancer Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Follicular Thyroid Cancer Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Follicular Thyroid Cancer Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Follicular Thyroid Cancer Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Follicular Thyroid Cancer Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Follicular Thyroid Cancer Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Follicular Thyroid Cancer Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Follicular Thyroid Cancer Drug Industry Trends
  2. 2.2 Follicular Thyroid Cancer Drug Industry Drivers
  3. 2.3 Follicular Thyroid Cancer Drug Industry Opportunities and Challenges
  4. 2.4 Follicular Thyroid Cancer Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Follicular Thyroid Cancer Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Follicular Thyroid Cancer Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Follicular Thyroid Cancer Drug Price (2021-2026)
  4. 3.4 Global Follicular Thyroid Cancer Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Follicular Thyroid Cancer Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Follicular Thyroid Cancer Drug Company, Product Type & Application
  7. 3.7 Global Follicular Thyroid Cancer Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Follicular Thyroid Cancer Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Follicular Thyroid Cancer Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Follicular Thyroid Cancer Drug Tier 1, Tier 2, and Tier 3
4 Follicular Thyroid Cancer Drug Regional Status and Outlook
  1. 4.1 Global Follicular Thyroid Cancer Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Follicular Thyroid Cancer Drug Historic Market Size by Region
  3. 4.2.1 Global Follicular Thyroid Cancer Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Follicular Thyroid Cancer Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Follicular Thyroid Cancer Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Follicular Thyroid Cancer Drug Forecasted Market Size by Region
  7. 4.3.1 Global Follicular Thyroid Cancer Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Follicular Thyroid Cancer Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Follicular Thyroid Cancer Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Follicular Thyroid Cancer Drug by Application
  1. 5.1 Follicular Thyroid Cancer Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Follicular Thyroid Cancer Drug Market Size by Application
  6. 5.2.1 Global Follicular Thyroid Cancer Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Follicular Thyroid Cancer Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Follicular Thyroid Cancer Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Follicular Thyroid Cancer Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Follicular Thyroid Cancer Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Follicular Thyroid Cancer Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Follicular Thyroid Cancer Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Follicular Thyroid Cancer Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Follicular Thyroid Cancer Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Follicular Thyroid Cancer Drug Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 GlaxoSmithKline plc
  14. 6.3.1 GlaxoSmithKline plc Company Information
  15. 6.3.2 GlaxoSmithKline plc Business Overview
  16. 6.3.3 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Product Portfolio
  18. 6.3.5 GlaxoSmithKline plc Recent Developments
  19. 6.4 Exelixis, Inc.
  20. 6.4.1 Exelixis, Inc. Company Information
  21. 6.4.2 Exelixis, Inc. Business Overview
  22. 6.4.3 Exelixis, Inc. Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Exelixis, Inc. Follicular Thyroid Cancer Drug Product Portfolio
  24. 6.4.5 Exelixis, Inc. Recent Developments
  25. 6.5 AstraZeneca PLC
  26. 6.5.1 AstraZeneca PLC Company Information
  27. 6.5.2 AstraZeneca PLC Business Overview
  28. 6.5.3 AstraZeneca PLC Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca PLC Follicular Thyroid Cancer Drug Product Portfolio
  30. 6.5.5 AstraZeneca PLC Recent Developments
7 North America by Country
  1. 7.1 North America Follicular Thyroid Cancer Drug Sales by Country
  2. 7.1.1 North America Follicular Thyroid Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Follicular Thyroid Cancer Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Follicular Thyroid Cancer Drug Market Size by Country
  6. 7.2.1 North America Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Follicular Thyroid Cancer Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Follicular Thyroid Cancer Drug Sales by Country
  2. 8.1.1 Europe Follicular Thyroid Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Follicular Thyroid Cancer Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Follicular Thyroid Cancer Drug Market Size by Country
  6. 8.2.1 Europe Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Follicular Thyroid Cancer Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Follicular Thyroid Cancer Drug Sales by Country
  2. 9.1.1 Asia-Pacific Follicular Thyroid Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Follicular Thyroid Cancer Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Follicular Thyroid Cancer Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Follicular Thyroid Cancer Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Follicular Thyroid Cancer Drug Sales by Country
  2. 10.1.1 South America Follicular Thyroid Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Follicular Thyroid Cancer Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Follicular Thyroid Cancer Drug Market Size by Country
  6. 10.2.1 South America Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Follicular Thyroid Cancer Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Follicular Thyroid Cancer Drug Sales by Country
  2. 11.1.1 Middle East and Africa Follicular Thyroid Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Follicular Thyroid Cancer Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Follicular Thyroid Cancer Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Follicular Thyroid Cancer Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Follicular Thyroid Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Follicular Thyroid Cancer Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Follicular Thyroid Cancer Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Follicular Thyroid Cancer Drug Value Chain Analysis
  2. 12.1.1 Follicular Thyroid Cancer Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Follicular Thyroid Cancer Drug Production Mode & Process
  7. 12.2 Follicular Thyroid Cancer Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Follicular Thyroid Cancer Drug Distributors
  10. 12.2.3 Follicular Thyroid Cancer Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst